BLACK PERSON;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE MONITORING;
CAUSE OF DEATH;
CHRONIC KIDNEY DISEASE;
CONSULTATION;
DEVELOPED COUNTRY;
DIABETIC PATIENT;
DIASTOLIC BLOOD PRESSURE;
DRUG INDICATION;
EUROPE;
FRANCE;
HUMAN;
HYPERTENSION;
MEDICAL SOCIETY;
PRACTICE GUIDELINE;
REVIEW;
SYSTOLIC BLOOD PRESSURE;
UNITED KINGDOM;
UNITED STATES;
ADULT;
AGE;
AGED;
BLOOD PRESSURE;
CLINICAL PRACTICE;
COMBINATION DRUG THERAPY;
COMORBIDITY;
DRUG EFFECTS;
EPIDEMIOLOGY;
ETHNOLOGY;
FEMALE;
MALE;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PATIENT REFERRAL;
PREDICTIVE VALUE;
RISK FACTOR;
STANDARDS;
TREATMENT OUTCOME;
VERY ELDERLY;
ADULT;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
BLOOD PRESSURE MONITORING, AMBULATORY;
COMORBIDITY;
DRUG THERAPY, COMBINATION;
EUROPE;
FEMALE;
GUIDELINE ADHERENCE;
HUMANS;
HYPERTENSION;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINES AS TOPIC;
PRACTICE PATTERNS, PHYSICIANS';
PREDICTIVE VALUE OF TESTS;
REFERRAL AND CONSULTATION;
RISK FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
[Management of arte-rial hypertension in adults: 2013 guidelines of the FrenchSociety of Arterial Hypertension]
Blacher J, Halimi JM, Hanon O, et al. [Management of arte-rial hypertension in adults: 2013 guidelines of the FrenchSociety of Arterial Hypertension]. Ann Cardiol Angeiol (Paris)2013;62:132-8.
2013 ESH/ESCGuidelines for the management of arterial hypertension: TheTask Force for the management of arterial hypertensionof the European Society of Hypertension (ESH) and of theEuropean Society of Cardiology (ESC)
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESCGuidelines for the management of arterial hypertension: theTask Force for the management of arterial hypertensionof the European Society of Hypertension (ESH) and of theEuropean Society of Cardiology (ESC). J Hypertens 2013;31:1281-357.
2014 evidence-based guide-line for the management of high blood pressure in adults: Reportfrom the panel members appointed to the Eighth Joint NationalCommittee (JNC 8)
James PA, Oparil S, Carter BL, et al. 2014 evidence-based guide-line for the management of high blood pressure in adults: reportfrom the panel members appointed to the Eighth Joint NationalCommittee (JNC 8). JAMA 2014;311:507-20.
Hypertension: the clinical management of primary hyperten-sion in adults London: National Clinical Guideline Centre
Hypertension: the clinical management of primary hyperten-sion in adults. Clinical Guideline 127: methods, evidence andrecommendations. London: National Clinical Guideline Centre;2011. Available at: https://www.nice.org.uk/guidance/cg127/evidence/cg127-hypertension-full-guideline3
Proportion of US adults potentially affected by the 2014hypertension guideline
Navar-Boggan AM, Pencina MJ, Williams K, Sniderman AD, Peter-son ED. Proportion of US adults potentially affected by the 2014hypertension guideline. JAMA 2014;311:1424-9.
Effects of an angiotensin-converting-enzyme inhibitor, ramipril,on cardiovascular events in high-risk patients
The Heart Out-comes Prevention Evaluation Study Investigators
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.Effects of an angiotensin-converting-enzyme inhibitor, ramipril,on cardiovascular events in high-risk patients. The Heart Out-comes Prevention Evaluation Study Investigators. N Engl J Med2000;342:145-53.
Cardiovascularmorbidity and mortality in the Losartan Intervention for End-point reduction in hypertension study (LIFE): A randomised trialagainst atenolol
Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascularmorbidity and mortality in the Losartan Intervention For End-point reduction in hypertension study (LIFE): a randomised trialagainst atenolol. Lancet 2002;359:995-1003.
Prevention of cardiovas-cular events with an antihypertensive regimen of amlodipineadding perindopril as required versus atenolol adding ben-droflumethiazide as required in the Anglo-ScandinavianCardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial
Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovas-cular events with an antihypertensive regimen of amlodipineadding perindopril as required versus atenolol adding ben-droflumethiazide as required, in the Anglo-ScandinavianCardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet2005;366:895-906.
